Women's Health & Pregnancy Clinical Trials

Statistical methods in women's health & pregnancy trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All women's health & pregnancy trials

790 results

• Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1/2Results postedn = 127NCT02030067
• Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013): Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 946NCT00535288
• Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD: Complete Statistical AnalysisIndependent statistical analysis of Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01210560).Phase 2Results postedn = 25NCT01210560
• Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 47NCT04351750
• Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 153NCT00667576
• Double-J PLUS Postmarket Registry Study: Complete Statistical AnalysisIndependent statistical analysis of Double-J PLUS Postmarket Registry Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04197583).Phase NAResults postedn = 379NCT04197583
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 102NCT00193037
• Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1/2Results postedn = 30NCT00331552
• DRIVEIndependent statistical analysis of Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 58NCT00465894
• DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 1Results postedn = 12NCT03368196
• DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]: primary endpoint results, effect estimate…Phase 3Results postedn = 524NCT03529110
• DUAOIndependent statistical analysis of Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00496080).Phase NAResults postedn = 87NCT00496080
• DWETRIndependent statistical analysis of A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 1Results postedn = 12NCT01367080
• DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: Complete Statistical AnalysisIndependent statistical analysis of DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03715452).Phase NAResults postedn = 114NCT03715452
• DYVINIAIndependent statistical analysis of Dysport in Vulvodynia Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598777).Phase 2Results postedn = 60NCT03598777
• e-DomSantéIndependent statistical analysis of Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 15NCT03359759
• E3 Breast Cancer Taxotere Combination: Complete Statistical AnalysisIndependent statistical analysis of E3 Breast Cancer Taxotere Combination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00494481).Phase 2Results postedn = 64NCT00494481
• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 390NCT01242800
• eCareIndependent statistical analysis of Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 538NCT04739696
• ECOR-HIndependent statistical analysis of Childhood Risk Reduction Program in Hispanics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03903146).Phase NAResults postedn = 40NCT03903146
• ECRIPIndependent statistical analysis of Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01725113).Phase 4Results postedn = 16NCT01725113
• EduCanIndependent statistical analysis of Effectiveness of a Modern Educational Intervention in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03351075).Phase NAResults postedn = 184NCT03351075
• Educational Program in Younger Women Who Have Recently Finished Treatment for Stage I or Stage II Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Educational Program in Younger Women Who Have Recently Finished Treatment for Stage I or Stage II Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 252NCT00416572
• Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 1NCT00856791
• Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 5NCT00603408
• Effect of Colostrum on Mucosal Immunity in Very Low Birth Weight (VLBWs) Premature Infants: Complete Statistical AnalysisIndependent statistical analysis of Effect of Colostrum on Mucosal Immunity in Very Low Birth Weight (VLBWs) Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 99NCT01776268
• Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH.: Complete Statistical AnalysisIndependent statistical analysis of Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 9NCT02389088
• Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009): Complete Statistical AnalysisIndependent statistical analysis of Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009): primary endpoint results, effect estimate with confidence…Phase 1Results postedn = 36NCT01948986
• Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia: Complete Statistical AnalysisIndependent statistical analysis of Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1/2Results postedn = 179NCT03101150
• Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 2NCT01126801
• Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD: Complete Statistical AnalysisIndependent statistical analysis of Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 35NCT01128179
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.: Complete Statistical AnalysisIndependent statistical analysis of Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 45NCT00446459
• Effects of Probiotic and Prebiotic Combinations on Premature Infants: Complete Statistical AnalysisIndependent statistical analysis of Effects of Probiotic and Prebiotic Combinations on Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00282113).Phase NAResults postedn = 90NCT00282113
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy: Complete Statistical AnalysisIndependent statistical analysis of Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy: primary endpoint results, effect estimate with confidence…Phase NAResults postedn = 28NCT00324675
• Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 741NCT01164501
• Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062): Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062): primary endpoint results, effect estimate…Phase 3Results postedn = 2,016NCT02616146
• Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 4Results postedn = 36NCT00965094
• Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 1,179NCT00306787
• Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 446NCT01067976
• Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303): Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 376NCT03734991
• Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 169NCT00962585
• Efficacy and Safety of Tenalisib (RP6530), in Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Tenalisib (RP6530), in Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 40NCT05021900
• Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 25NCT01842542
• Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 16NCT03190083
• Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 1NCT03560102
• Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03859024).Phase 4Results postedn = 48NCT03859024
• Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 15NCT05900050
• EFforT-BCRLIndependent statistical analysis of Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02609724).Phase NAResults postedn = 194NCT02609724
• Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney): Complete Statistical AnalysisIndependent statistical analysis of Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03149328).Phase NAResults postedn = 594NCT03149328
• ELPISIndependent statistical analysis of Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy: primary endpoint results, effect estimate with…Phase 2Results postedn = 5NCT04578106

← All therapeutic areas